(firstQuint)The Efficacy and Safety of Thymosin-1 in Patients With HBV-related ACLF.

.

 Hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) is a severe disease with high mortality.

 In this study, we intend to assess the efficacy and safety of Thymosin-1 in patients with HBV-related Acute-on-chronic liver failure.

.

 The Efficacy and Safety of Thymosin-1 in Patients With HBV-related ACLF.

@highlight

A randomized controlled trial to evaluate efficacy and safety of Thymosin-1 administration in patients with HBV-related Acute-on-chronic liver failure.

